dihydroergotamine has been researched along with pindolol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ashkenazi, A; Havlik, S; Jin, H; Marsters, SA; O'Dowd, BF; Oksenberg, D; Peroutka, SJ | 1 |
| Ariani, K; Ciaranello, RD; Hamblin, MW; Stratford, CA; Tan, GL | 1 |
| Christensen, NJ; Hilsted, J | 1 |
| Bircher, J; Bührer, M; Isenschmid, M; Müller, M | 1 |
| Schirger, A; Schwartz, GL | 1 |
| Bai, F; Cherezov, V; Gao, X; Han, GW; Huang, XP; Jiang, H; Jiang, Y; Katritch, V; Liu, W; Ma, J; McCorvy, JD; Melcher, K; Roth, BL; Stevens, RC; Vardy, E; Wacker, D; Wang, C; Wu, H; Xu, HE; Yang, H; Yang, L; Zhang, C; Zhou, XE | 1 |
2 review(s) available for dihydroergotamine and pindolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment of orthostatic hypotension.
Topics: Autonomic Nervous System Diseases; Cardiac Pacing, Artificial; Combined Modality Therapy; Diabetic Neuropathies; Dihydroergotamine; Fludrocortisone; Head; Humans; Hypotension, Orthostatic; Phenylephrine; Pindolol; Plasma Volume; Posture | 1985 |
5 other study(ies) available for dihydroergotamine and pindolol
| Article | Year |
|---|---|
A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors.
Topics: Alprenolol; Amino Acid Sequence; Animals; Base Sequence; Dihydroergotamine; Humans; In Vitro Techniques; Methiothepin; Methysergide; Mice; Molecular Sequence Data; Pindolol; Propranolol; Rats; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1992 |
G protein dependent alterations in [125I]iodocyanopindolol and +/- cyanopindolol binding at 5-HT1B binding sites in rat brain membranes.
Topics: Animals; Binding, Competitive; Brain; Cell Membrane; Dihydroergotamine; Ethylmaleimide; GTP-Binding Proteins; Guanosine Diphosphate; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Iodocyanopindolol; Magnesium Sulfate; Pindolol; Rats; Receptors, Serotonin | 1989 |
[Automatic finger plethysmography as a human pharmacologic research tool. A methodologic study].
Topics: Adult; Blood Pressure; Dihydroergotamine; Ethanol; Female; Fingers; Heart Rate; Humans; Male; Pindolol; Plethysmography; Pulse; Regional Blood Flow; Temperature; Time Factors | 1984 |
Orthostatic hypotension.
Topics: Cerebrovascular Circulation; Clonidine; Deamino Arginine Vasopressin; Dihydroergotamine; Dopamine; Epinephrine; Humans; Hypotension, Orthostatic; Metoclopramide; Octreotide; Patient Education as Topic; Pindolol; Yohimbine | 1994 |
Structural basis for molecular recognition at serotonin receptors.
Topics: Amino Acid Sequence; Binding Sites; Crystallography, X-Ray; Dihydroergotamine; Ergotamine; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Ligands; Lysergic Acid Diethylamide; Models, Molecular; Molecular Docking Simulation; Molecular Sequence Data; Mutagenesis; Norfenfluramine; Pindolol; Propranolol; Protein Conformation; Protein Folding; Protein Structure, Secondary; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Agonists; Tryptamines | 2013 |